Eric Schroeder, MD, discusses how treatments for patients with ovarian cancer have evolved in recent years.
Eric Schroeder, MD
Advertisement
Eric Schroeder, MD, is a gynecologic oncologist at Miami Cancer Institute.
Articles by Eric Schroeder, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Alpelisib/Fulvestrant Improves PFS in Post-CDK4/6 HR+/HER2- Breast Cancer
2
Gedatolisib Improves PFS in HR+/HER2-/PIK3CA-WT Advanced Breast Cancer
3
FDA Approves Niraparib/Abiraterone Combo for BRCA2-Mutated mCSPC
4
Nadunolimab Misses Efficacy Mark in TNBC, Despite Strong OS
5
